Literature DB >> 12359359

Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells.

Yuko Harimaya1, Keiichi Koizumi, Tsugunobu Andoh, Hiroshi Nojima, Yasushi Kuraishi, Ikuo Saiki.   

Abstract

Morphine is frequently used for cancer patient's terminal medical care to relieve cancer pain. In the present study, we examined the inhibitory effect of morphine on experimental lung metastasis and invasion of colon 26-L5 cells. Morphine was found to significantly reduce the number of tumor colonies and the weight of the tumor-containing lung. Morphine inhibited the adhesion and migration of colon 26-L5 cells to extracellular matrix components and invasion into reconstituted basement membrane Matrigel, without affecting the cell proliferation in vitro. Notably, naloxone, an antagonist of morphine, abrogated morphine-induced inhibition of tumor cell adhesion, but did not affect the inhibitory effect on the production of matrix metalloproteinases (MMPs) from tumor cells. These results suggest that morphine inhibited the adhesive and invasive properties of tumor cells by different inhibitory mechanisms that involved the mediation of an opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359359     DOI: 10.1016/s0304-3835(02)00360-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  [Use of methadone for support of oncological treatment? : Statement of the working group on tumor pain of the German Pain Society].

Authors:  H Hofbauer; M Schenk; K Kieselbach; S Wirz
Journal:  Schmerz       Date:  2017-02       Impact factor: 1.107

Review 2.  Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.

Authors:  David Brinkman; Jiang H Wang; Henry P Redmond
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000

Review 3.  Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

Authors:  B Afsharimani; C W Doornebal; P J Cabot; M W Hollmann; M-O Parat
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 4.  Morphine: double-faced roles in the regulation of tumor development.

Authors:  X Y Zhang; Y X Liang; Y Yan; Z Dai; H C Chu
Journal:  Clin Transl Oncol       Date:  2017-11-10       Impact factor: 3.405

5.  Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.

Authors:  Nan Xie; Samira Khabbazi; Zeyad D Nassar; Kye Gregory; Tharindu Vithanage; Bela Anand-Apte; Peter J Cabot; David Sturgess; Paul N Shaw; Marie-Odile Parat
Journal:  FASEB J       Date:  2017-08-07       Impact factor: 5.191

Review 6.  Methadone as anticancer treatment: hype, hope, or hazard? : A series of case reports and a short review of the current literature and recommendations of the societies.

Authors:  Gudrun Kreye; Eva-Katharina Masel; Klaus Hackner; Beate Stich; Friedemann Nauck
Journal:  Wien Med Wochenschr       Date:  2018-02-19

7.  Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC.

Authors:  Funda Ustun; Gülay Durmus-Altun; Semsi Altaner; Nermin Tuncbilek; Cem Uzal; Sakir Berkarda
Journal:  Med Oncol       Date:  2010-06-22       Impact factor: 3.064

8.  The effects of anesthetics on tumor progression.

Authors:  Lifang Mao; Suizhen Lin; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

Review 9.  Chronic opioid therapy in long-term cancer survivors.

Authors:  A Carmona-Bayonas; P Jiménez-Fonseca; E Castañón; A Ramchandani-Vaswani; R Sánchez-Bayona; A Custodio; D Calvo-Temprano; J A Virizuela
Journal:  Clin Transl Oncol       Date:  2016-07-21       Impact factor: 3.405

Review 10.  Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?

Authors:  Hidetomo Niwa; David J Rowbotham; David G Lambert; Donal J Buggy
Journal:  J Anesth       Date:  2013-05-14       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.